0001367644-21-000087.txt : 20210524
0001367644-21-000087.hdr.sgml : 20210524
20210524170113
ACCESSION NUMBER: 0001367644-21-000087
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210520
FILED AS OF DATE: 20210524
DATE AS OF CHANGE: 20210524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: White Marvin L
CENTRAL INDEX KEY: 0001493324
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 21955839
MAIL ADDRESS:
STREET 1: 2273 RESEARCH BLVD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4
1
wf-form4_162189005445348.xml
FORM 4
X0306
4
2021-05-20
0
0001367644
Emergent BioSolutions Inc.
EBS
0001493324
White Marvin L
400 PROFESSIONAL DRIVE
GAITHERSBURG
MD
20879
1
0
0
0
Common Stock
2021-05-20
4
A
0
5027
0
A
8656
D
Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.
These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company.
/s/ S. Scott Lieberman, Attorney-in-fact
2021-05-24